Evidence map›Paper›PMID 34702214›Full record

ArticleBMC neurology2021

Parkinsonism and dysautonomia with anti-CV2/CRMP5 associated paraneoplastic neurological syndromes mimicking multiple system atrophy: a case report.

Jia Song, Ying Zhang, Yue Lang, Yi-Heng Wang, Jie Shao, Li Cui

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Multiple system atrophy.Practical neurology · 2023
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Jia Song *Department of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China.
Ying Zhang *Department of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China.
Yue LangDepartment of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China.
Yi-Heng WangDepartment of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China.
Jie ShaoDepartment of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China.
Li CuiDepartment of Neurology, Jilin University First Hospital, Xinmin Street 1, Changchun, Jilin, China. lcui@jlu.edu.cn.ORCID http://orcid.org/0000-0002-4254-6736
Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParaneoplastic neurological syndromes (PNSs) are broad-spectrum disorders that can affect any part of the nervous system varying in core symptoms. Onconeural antibodies, including Hu, Yo, Ri, anti-CV2, amphiphysin, Ma2, and Tr are well-characterized and commonly used for the diagnosis of definite PNS. Generally, anti-CV2 antibodies have usually been associated with cerebellar ataxia, chorea, peripheral and autonomic neuropathies, myelopathy, optic neuritis, and retinitis. However, Parkinsonism has not been reported as the core symptom in patients with anti-CV2 antibodies. CASE PRESENTATION: We report a patient with anti-CV2 antibody manifested as Parkinsonism and autonomic dysfunction, which may lead to the diagnosis of multiple system atrophy with predominant Parkinsonism (MSA-P). A lumbar puncture examination was undergone to find a positive anti-CV2 antibody in cerebrospinal fluid. PET-CT showed no tumor. Immunotherapy was adopted and the symptoms were relieved for 5 months. However, with no evidence of tumor, he died after 8 months.

conclusionsOur findings indicate that PNS with anti-CV2 antibody can be shown as MSA-P mimic. Considering that MSA is a neurodegenerative disease with a poor prognosis, screening for other treatable or controllable factors like PNS presented in this case is necessary when encountering a rapid progressive MSA-mimic patient.

Indexed as

Multiple System AtrophyParaneoplastic Syndromes, Nervous SystemParkinsonian DisordersPrimary DysautonomiasAutoantibodiesHumansMalePositron Emission Tomography Computed TomographyAutoantibodiesAnti-CV2 antibodyCollapsin response mediated protein 5DysautonomiaMultiple system atrophyParaneoplastic syndrome

Identifiers

PMID34702214
PMCPMC8547084
OpenAlexW3208721338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.